Moderna is going head-to-head with Pfizer-BioNTech for the opportunity to vaccinate the youngest children, the only Americans still not eligible for shots.
The coronavirus vaccine made by Pfizer-BioNTech is much less effective in preventing infection in children ages 5-11 than in older adolescents or adults, according to a new set of data collected by health officials in New York state.